精准医学时代膀胱癌膀胱壁精确分期:目标是否已实现?
膀胱癌的术前病理分期依赖膀胱镜和经尿道膀胱肿瘤电切术,但存在侵入性、取样不足和分期不准确的问题。MRI已成为广泛接受的无创替代方法,可补充形态学数据并提供功能信息,提高肿瘤表征并预测逼尿肌组织学分级和浸润状态。影像组学有望提高膀胱癌分期和再分期的准确性,并指导治疗团队调整管理方案。
要点
- MRI作为无创替代方法,可补充形态学数据并提供肿瘤微环境的功能信息。
- 放射科医生预测逼尿肌浸润性和病理分级对个体化治疗决策至关重要。
- 影像组学有望提高膀胱癌分期和再分期的准确性,并指导治疗调整。
核心结论
- MRI已成为广泛接受的无创替代方法,补充形态学数据并提供功能信息,增强肿瘤表征并预测逼尿肌组织学分级和浸润状态;影像组学有望提高分期和再分期准确性并指导治疗调整。
关键影像表现/征象
- MRI可补充形态学数据并提供肿瘤微环境的功能信息,增强肿瘤表征并预测逼尿肌组织学分级和浸润状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Urinary bladder cancer is a global disease that poses medical and socioeconomic challenges to patients and healthcare systems. Predicting detrusor invasiveness and pathological grade of bladder cancer by the radiologist is imperative for informed decision-making and effective patient-tailored therapy. Cystoscopy and TURBT are the current gold standard for preoperative histologic diagnosis and local pathological staging but are compromised by their intrusiveness, under-sampling, and staging inaccuracies. Over the last few decades, incredible imaging technology advancements have enabled radiologists to progress in these grading and staging tasks. MRI has become widely accepted as a noninvasive alternative. It supplements morphologic data with functional insights into the tumor microenvironment, enhancing tumor characterization and predicting the detrusor's histologic grade and invasiveness status. Radiomics is a promising field that helps radiologists achieve higher accuracies in bladder cancer staging, re-staging, and direct treating teams to potential management readjustments. Such knowledge leaps hold promise for personalized management of bladder cancer in a precision medicine era.
引用
- Nouh MR, Ezz Eldin O. Precise vesical wall staging of bladder cancer in the era of precision medicine: has it been fulfilled? Abdom Radiol (NY). 2024. PMID: 39725735. doi:10.1007/s00261-024-04786-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。